May 3, 2019 Price forecast | 2 weeks: 0.40% | 1 month: 1.74% | 3 months: 3.60%


IDXX stock forecast

Our latest prediction for IDEXX Laboratories, Inc.'s stock price was made on the May 3, 2019 when the stock price was at 250.47$.

In the short term (2weeks), IDXX's stock price should outperform the market by 0.40%. During that period the price should oscillate between -3.48% and +3.44%.

In the medium term (3months), IDXX's stock price should outperform the market by 3.60%. During that period the price should oscillate between -7.69% and +11.68%.


About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: CAG, Water, LPD, and Other. The CAG segment develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services, which are used to manage the health status of livestock and poultry, to improve producer, and to ensure the quality and safety of milk and food. The Other operating segment combines and presents products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983 and is headquartered in Westbrook, ME.

At the moment the company generates 2252M USD in revenues.

On its last earning announcement, the company reported a profit of 4.42$ per share.

The book value per share is -0.47$

IDEXX Laboratories, Inc. website


Three months stock forecastMay 3, 2019


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
2252M 56.40% 511M 22.70% 390M 4.42 - - 88M -0.47 400M -137M 262M